Product apis-gpcr-g-protein

Home > products > apis> gpcr-g-protein

Catalog	name	Description	price
R-R-3570	Doxofylline-d6 CAS No.1219805-99-8	Doxofylline-d6/CAS No.1219805-99-8 is the deuterium labeled Doxofylline. Doxofylline is an antagonist of adenosine A1 receptor which also inhibits phosphodiesterase IV.	price>
R-R-3571	LUF6096 CAS No.1116652-18-6	LUF6096/CAS No.1116652-18-6, a potent allosteric enhancer of the adenosine A3 receptor, is able to allosterically enhance agonist binding. LUF6096 shows low orthosteric affinity for any of the adenosine receptors. LUF6096 shows protective effects in myocardial ischemia/reperfusion injury.	price>
R-R-3572	Theobromine-d3 CAS No.65566-69-0	Theobromine-d3/CAS No.65566-69-0 is the deuterium labeled Theobromine. Theobromine is a methylxanthine found in cacao beans which can inhibit adenosine receptor A1 (AR1) signaling.	price>
R-R-3573	KFM19 CAS No.133058-72-7	KFM19/CAS No.133058-72-7 is a potent, selective Adenosine receptor (A1-receptor) antagonist, with an IC50 of 50 nM.	price>
R-R-3574	PSB-1115 CAS No.152529-79-8	PSB-1115/CAS No.152529-79-8 is a selective A2B Adenosine Receptor antagonist. PSB-1115 inhibits the 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced contraction inhibition of acetylcholine (ACh).	price>
R-R-3575	GP531 CAS No.142344-87-4	GP531/CAS No.142344-87-4 is a potent, second-generation adenosine regulating agent, is pharmacologically silent under basal conditions but increases localized endogenous adenosine during ischemia.	price>
R-R-3576	Adenosine receptor antagonist 3 CAS No.2400864-80-2	Adenosine receptor antagonist 3/CAS No.2400864-80-2 is a potent antagonist of adenosine receptor. Adenosine receptor antagonist 3 has the potential for the research of cancer disease (extracted from patent WO2019233994A1, compound 1).	price>
R-R-3577	Inupadenant hydrochloride CAS No.2411004-22-1	Inupadenant (EOS-850) hydrochloride/CAS No.2411004-22-1 is an orally active, highly selective A2A receptor antagonist. Inupadenant hydrochloride is not brain-penetrant. Inupadenant hydrochloride has potent anti-tumor activity.	price>
R-C-1878	AZD-7594 CAS:1196509-60-0	AZD-7594(AZ13189620)is an inhaled selective glucocorticoid receptor(GCCR)modulator.AZD-7594 is in phase II clinical trials by AstraZeneca for the treatment of mild to moderate asthma.It is also in phase I clinical trials for the treatment of chronic obstructive pulmonary disorder(COPD).	price>
R-R-3578	Sipagladenant CAS No.858979-50-7	Sipagladenant (Compound I)/CAS No.858979-50-7 is an orally active adenosine receptor A2A inverse agonist. Sipagladenant can be used in frontal lobe dysfunction research.	price>

...

163